Kaitai Capital logo

Kaitai Capital

Asia, Zhejiang, China, Hangzhou

Description

Kaitai Capital is a professional investment management organization.

Investor Profile

Kaitai Capital has made 25 investments, with 1 in the past 12 months and 12% as lead.

Stage Focus

  • Series A (28%)
  • Seed (28%)
  • Series C (16%)
  • Series B (12%)
  • Angel (8%)
  • Series D (4%)
  • Series Unknown (4%)

Country Focus

  • United States (56%)
  • China (44%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Oncology
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Biopharma
  • 3d Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kaitai Capital frequently co-invest with?

Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
Capital Community Angel Investors
North America, Michigan, United States, East Lansing
Co-Investments: 2
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 2
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 2
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Legend Star
Asia, Beijing, China, Beijing
Co-Investments: 2
Biosciences Research and Commercialization Center (BRCC)
North America, Michigan, United States, Kalamazoo
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 3

Which angels does Kaitai Capital often collaborate with?

AI
Europe, Cyprus
Shared Deals: 1
FB
North America, New York, United States, New York
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Kaitai Capital?

Sheng Sheng Biology

Zhangshan, Guangdong, China

Sheng Sheng Biology is a biotechnology company that provides medical research and experimental development services.

BiotechnologyHealth CareMedical
Series ANov 21, 2024
Atom Bioscience & Pharmaceutical

Suzhou, Jiangsu, China

Atom Bioscience is a clinical-stage biotechnology company.

BiotechnologyHealth Care
Series DOct 16, 2023
Amount Raised: $82,075,975
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 8, 2023
Amount Raised: $15,000,000
Rgenta Therapeutics

Cambridge, Massachusetts, United States

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

BiotechnologyHealth CareMedicalOncologyPharmaceuticalTherapeutics
Series ANov 29, 2022
Amount Raised: $52,000,000
Lupeng Pharmaceutical

Guangzhou, Guangdong, China

Lupeng Pharmaceutical is a biotech company that focuses on the drug discovery and development of novel therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series ANov 14, 2022
Amount Raised: $35,000,000
Realibox

Guangzhou, Guangdong, China

Realibox delivers digital designing and cloud platform solutions for enterprises.

3D TechnologyCloud InfrastructureWeb Design
Series ASep 26, 2022
Amount Raised: $13,987,970
Paradromics

Austin, Texas, United States

Paradromics is developing high data rate brain computer interfacing technology

Health CareMedical DeviceNeuroscience
Series UnknownSep 21, 2022
Amount Raised: $8,864,853
Bivision

Shanghai, Shanghai, China

Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).

BiopharmaBiotechnologyHealth Diagnostics
AngelAug 10, 2022
Amount Raised: $14,872,542
Worktile

Beijing, Beijing, China

Worktile is a Enterprise services Startup Based in Beijing.

EnterpriseEnterprise Applications
Series CApr 25, 2022
Amount Raised: $15,245,297
Xihu Xinchen

Hangzhou, Zhejiang, China

Xihu Xinchen is a technology company focusing on the research and development of artificial intelligence services.

Artificial Intelligence (AI)Consulting
SeedDec 23, 2021
Amount Raised: $10,000,000